Category: Federal Forum Posters
Purpose: Oklahoma is currently experiencing an opioid abuse and overuse crisis; of all unintentional poisoning deaths in 2016, involving drugs or alcohol, narcotic analgesics accounted for nearly half. Despite state and national initiatives abuse potential of opioids, and associated poor outcomes, remains high. The risk of respiratory depression for these patients is further increased by concurrent prescribing of muscle relaxers and benzodiazepines. Implementation of a pharmacist-led naloxone distribution service has the potential to save lives. Standardized prescribing practices and education throughout the health system can help ensure that patients at risk are protected from the dangers of opioid overdose.
Methods: Pharmacists will be trained how to identify and educate high risk patients eligible for pharmacist prescribing of naloxone. Pharmacists involved will be required to complete an education module and competency exam in order to comply with health-system policy on naloxone prescribing. The educational module will also contain information on intranasal naloxone administration, patient education, documentation, and follow-up. High risk patients will be identified via the electronic medical record as those receiving chronic opioid therapy, with a benzodiazepine, and muscle relaxer in the same time period. Patients meeting high risk criteria will be assessed for the best contact method based on their patient profile. These patients will then be either counseled following prescription refills or contacted by phone to schedule a visit. Scheduled face-to-face visits will be prioritized and the patient will be encouraged to bring a family member if possible. During the visit the patient will also be provided with training on intranasal naloxone, counseled over use, and receive the product. Patients will also be encouraged to report use back to the pharmacy, or followed-up at a 90 day interval, so that the product can be re-prescribed, and use can be tracked.
Results: not applicable
Conclusion: not applicable
Sarah Johnston– PGY1 Pharmacy Resident, Chickasaw Nation Department of Health, Ada, OK